Everise Appoints Robert Jimenez as Chief Revenue Officer

Everise, a global leader in transforming customer experiences, announced Appointment of  Robert Jimenez joins as Chief Revenue Officer (CRO).

With more than 25 years of leadership experience at some of the most recognized global BPO and consulting firms, Robert Jimenez most recently served as CRO of Teleperformance. He has led transformative growth strategies for the likes of Cognizant, TTEC, Genpact, Capgemini, and IBM. Known for building high-performance global sales teams and forging long-term client relationships, he has delivered a consistent track record of growth while balancing profitability and innovation. As CRO, Robert will be responsible for driving Everise’s global growth strategy and all elements of commercial operations, including sales, growth marketing, and pricing strategies.

“I am honored to join Everise and be part of such a talented, passionate team. Everise has built a reputation for innovation, exceptional service, and a culture that truly values people. I look forward to partnering with our leaders and clients to capture the next wave of growth, expand into new markets, and continue delivering outstanding experiences in every interaction,” shared Robert Jimenez, Chief Revenue Officer, Everise.

Also Read: 8×8 Boosts Customer Engagement with New AI Enhancements Across CX Platform

Everise is a global leader transforming customer service for the healthcare, transport, logistics, insurance, financial services, and tech sectors. Backed by Brookfield and Warburg Pincus, the company solves problems for the millions of customers of the world’s leading brands by combining the best technology with compassionate service. With 28,000 champion agents operating across eight strategic markets globally our customer service solutions are high-performing, secure, and agile, enabling businesses to scale globally while achieving top customer satisfaction.

SOURCE: PRNewswire

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More